134 related articles for article (PubMed ID: 32928023)
1. Could angiotensin-converting enzyme 1
Dević Pavlić S; Nadalin S; Starčević Čizmarević N; Buretić-Tomljanović A; Radojčić Badovinac A; Ristić S
J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320957157. PubMed ID: 32928023
[No Abstract] [Full Text] [Related]
2. COVID-19 infections are also affected by human ACE1 D/I polymorphism.
Delanghe JR; Speeckaert MM; De Buyzere ML
Clin Chem Lab Med; 2020 Jun; 58(7):1125-1126. PubMed ID: 32286246
[No Abstract] [Full Text] [Related]
3. Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
Tsiambas E; Papanikolaou V; Chrysovergis A; Mastronikolis N; Ragos V; Kavantzas N; Lazaris AC; Kyrodimos E
Pathol Oncol Res; 2020 Oct; 26(4):2823-2825. PubMed ID: 32333199
[No Abstract] [Full Text] [Related]
4. Host Polymorphisms May Impact SARS-CoV-2 Infectivity.
Brest P; Refae S; Mograbi B; Hofman P; Milano G
Trends Genet; 2020 Nov; 36(11):813-815. PubMed ID: 32828550
[TBL] [Abstract][Full Text] [Related]
5. Genetic predisposition models to COVID-19 infection.
Darbeheshti F; Rezaei N
Med Hypotheses; 2020 Sep; 142():109818. PubMed ID: 32416414
[No Abstract] [Full Text] [Related]
6. A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2.
Su S; Jiang S
Signal Transduct Target Ther; 2020 May; 5(1):71. PubMed ID: 32435059
[No Abstract] [Full Text] [Related]
7. The host's angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections.
Delanghe JR; Speeckaert MM; De Buyzere ML
Clin Chim Acta; 2020 Jun; 505():192-193. PubMed ID: 32220422
[No Abstract] [Full Text] [Related]
8. [Are there genetic variants that can modify the course of the COVID-19 pandemic?].
Azurmendi PJ
Medicina (B Aires); 2020; 80 Suppl 3():79-81. PubMed ID: 32658852
[No Abstract] [Full Text] [Related]
9. Correction: Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission.
Clin Sci (Lond); 2020 Sep; 134(17):2315-2317. PubMed ID: 32901820
[No Abstract] [Full Text] [Related]
10. Sex-mediated effects of ACE2 and TMPRSS2 on the incidence and severity of COVID-19; The need for genetic implementation.
Alshahawey M; Raslan M; Sabri N
Curr Res Transl Med; 2020 Nov; 68(4):149-150. PubMed ID: 32917573
[No Abstract] [Full Text] [Related]
11. COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.
Tan CS; Yeoh SF; Long CM
Ann Acad Med Singap; 2020 Jun; 49(6):398-400. PubMed ID: 32712639
[No Abstract] [Full Text] [Related]
12. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
Guo X; Chen Z; Xia Y; Lin W; Li H
J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 challenging cell biology.
Bullerdiek J
Protoplasma; 2020 May; 257(3):619-620. PubMed ID: 32333127
[No Abstract] [Full Text] [Related]
14. Skin is a potential host of SARS-CoV-2: A clinical, single-cell transcriptome-profiling and histologic study.
Sun Y; Zhou R; Zhang H; Rong L; Zhou W; Liang Y; Li Q
J Am Acad Dermatol; 2020 Dec; 83(6):1755-1757. PubMed ID: 32822795
[No Abstract] [Full Text] [Related]
15. Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome.
Gómez J; Albaiceta GM; García-Clemente M; López-Larrea C; Amado-Rodríguez L; Lopez-Alonso I; Hermida T; Enriquez AI; Herrero P; Melón S; Alvarez-Argüelles ME; Boga JA; Rojo-Alba S; Cuesta-Llavona E; Alvarez V; Lorca R; Coto E
Gene; 2020 Dec; 762():145102. PubMed ID: 32882331
[TBL] [Abstract][Full Text] [Related]
16. Expression Pattern of the SARS-CoV-2 Entry Genes
Liu Y; Qu HQ; Qu J; Tian L; Hakonarson H
Viruses; 2020 Oct; 12(10):. PubMed ID: 33081421
[TBL] [Abstract][Full Text] [Related]
17. Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.
Murray E; Tomaszewski M; Guzik TJ
Cardiovasc Res; 2020 Jun; 116(7):e87-e89. PubMed ID: 32301968
[No Abstract] [Full Text] [Related]
18. [Genetic and epigenetic variability, and the Covid-19 pandemic].
Rivera-Silva G
Salud Publica Mex; 2020; 62(5):462-463. PubMed ID: 32668509
[No Abstract] [Full Text] [Related]
19. Covid-19 infection and the host genetic predisposition: does it exist?
Vašků A
Physiol Res; 2020 Jul; 69(3):511-514. PubMed ID: 32682363
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.
Milne S; Yang CX; Timens W; Bossé Y; Sin DD
Lancet Respir Med; 2020 Jun; 8(6):e50-e51. PubMed ID: 32411576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
